Digging Up the Facts on Immunomedics, Inc. (IMMU)

Immunomedics, Inc. (IMMU) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $19.51, up from yesterday’s close by 3.89%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Immunomedics, Inc. (IMMU) currently trades with a market capitalization of $3.21 Billion. That value represents a market adjusting for revenues that have been falling by -63.56 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$115.95 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of -$0.15 on a per share basis this quarter. Perhaps, that suggests something about why 1.39% of the outstanding share supply is held by institutional investors.



Technical Analysis

It’s important to check the technicals to get a sense of how IMMU has been acting. Looking at the stock’s movement on the chart, Immunomedics, Inc. recorded a 52-week high of $19.90. It is now trading 0.39% off that level. The stock is trading $16.61 its 50-day moving average by -2.9%. The stock carved out a 52-week low down at $6.98.

In recent action, Immunomedics, Inc. (IMMU) has made a move of +15.58% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.61, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 19.41% with $146.43 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of IMMU.

SHARE
Previous articleTaking a Look at the Data Behind Sangamo Therapeutics, Inc. (SGMO)
Next articleThe Interpublic Group of Companies, Inc. (IPG): What’s the Story?